Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$113,716
in 1 filing, $114K under 10b5-1 plans

Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Podlesak Dennis −$114K Director sold 3% of stake

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-10-30 Meyers Michael L. SVP, Chief Medical Officer Purchase +200 $4.79 $958 2,398
2018-09-25 Jarrett Jennifer Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2018-09-25 Meury William Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2018-06-18 BVF PARTNERS L P/IL 10% owner Other disposition −1,105,391 498,025
2018-06-18 BVF PARTNERS L P/IL 10% owner Other disposition −705,863 318,021
2018-06-18 BVF PARTNERS L P/IL 10% owner Other disposition −188,746 85,038
2018-06-18 BVF PARTNERS L P/IL 10% owner Other acquisition · Warrants +1,105,391 1,105,391
2018-06-18 BVF PARTNERS L P/IL 10% owner Other acquisition · Warrants +705,863 705,863
2018-06-18 BVF PARTNERS L P/IL 10% owner Other acquisition · Warrants +188,746 188,746
2018-05-23 Chen Henry Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2018-05-23 Egros Fabrice Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2018-05-23 EVNIN LUKE Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2018-05-23 Katkin Keith Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2018-05-23 Legault Pierre Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2018-05-23 Podlesak Dennis Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2018-04-03 Ordentlich Peter Chief Scientific Officer Option exercise +7,500 $3.08 $23K 7,500
2018-04-03 Ordentlich Peter Chief Scientific Officer Sale −7,500 $15.00 $113K 0
2018-04-03 Ordentlich Peter Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) −7,500 0
2018-03-01 Shea Richard P Chief Financial Officer Grant or award · Stock Option (Right to Buy) +48,000 48,000
2018-03-01 Ordentlich Peter Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +40,000 40,000

Page 24 of 25 · 500 trades